当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tumor-infiltrating lymphocytes make inroads in non–small-cell lung cancer
Nature Medicine ( IF 82.9 ) Pub Date : 2021-08-12 , DOI: 10.1038/s41591-021-01445-z
Joshua R Veatch 1, 2 , Sylvain Simon 1 , Stanley R Riddell 1, 2
Affiliation  

A phase 1 trial shows promising anti-tumor activity of tumor-infiltrating-lymphocyte therapy in patients with advanced non–small-cell lung cancer.

中文翻译:

肿瘤浸润淋巴细胞侵入非小细胞肺癌

一项一期试验显示,肿瘤浸润淋巴细胞疗法对晚期非小细胞肺癌患者具有良好的抗肿瘤活性。
更新日期:2021-08-12
down
wechat
bug